Search

Your search keyword '"Bomback, Andrew"' showing total 361 results

Search Constraints

Start Over You searched for: Author "Bomback, Andrew" Remove constraint Author: "Bomback, Andrew" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
361 results on '"Bomback, Andrew"'

Search Results

3. Increased risk of kidney failure in patients with genetic kidney disorders

4. Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis

6. Rationale and design of the Kidney Precision Medicine Project

9. The Significance of Hematuria in Podocytopathies

10. Urinary EGF and MCP-1 and risk of CKD after cardiac surgery.

11. Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease

12. Implementation and Feasibility of Clinical Genome Sequencing Embedded Into the Outpatient Nephrology Care for Patients With Proteinuric Kidney Disease

13. Molecular Signatures of Glomerular Neovascularization in a Patient with Diabetic Kidney Disease

14. Participant Experience with Protocol Research Kidney Biopsies in the Kidney Precision Medicine Project

17. Rare Single Nucleotide and Copy Number Variants and the Etiology of Congenital Obstructive Uropathy: Implications for Genetic Diagnosis

18. Cadherin-11, Sparc-related modular calcium binding protein-2, and Pigment epithelium-derived factor are promising non-invasive biomarkers of kidney fibrosis

21. Longitudinal Changes in Health-Related Quality of Life in Primary Glomerular Disease: Results From the CureGN Study

22. Persistent Disease Activity in Patients With Long-Standing Glomerular Disease

25. Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations

27. Factor B Inhibition with Iptacopan in Recurrent C3 Glomerulopathy Following Kidney Transplant: A Report of Two Cases

28. WCN24-683 EFFICACY OF 12-WEEK PEGCETACOPLAN IN KIDNEY TRANSPLANT RECIPIENTS WITH RECURRENT C3 GLOMERULOPATHY (C3G) OR IMMUNE COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN)

29. Treatment Patterns Among Adults and Children With Membranous Nephropathy in the Cure Glomerulonephropathy Network (CureGN)

30. Health-related quality of life in glomerular disease

31. Real-world experience with avacopan in ANCA-associated vasculitis

33. Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse podocytopathy in the kidney allograft

35. Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts

36. Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study

38. Awareness of Kidney Disease and Relationship to End-stage Renal Disease and Mortality

43. The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis

44. Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

49. Rationale and design of the Kidney Precision Medicine Project

50. Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis

Catalog

Books, media, physical & digital resources